RAP 0.00% 20.5¢ raptor resources limited

Ann: ResAppDx-EU for Adult Respiratory Disease Receives CE Mark, page-25

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
  1. Dhm
    2,393 Posts.
    lightbulb Created with Sketch. 3512
    I believe the Chinese need country of origin approval - TGA - so application can be made there. FDA is frustrating; they haven't begun trials for adults yet. Anyhow, no negative thoughts today!
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.